ST
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.044
Exchange
XLON - London Stock Exchange
2 %
Last period Average growth rate (2y)
-51%
Average growth rate (2y) has decreased in 5 years
What is Average growth rate (2y) ?
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
See also Shield Therapeutics
Company Analysis
STX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
STX.L financial analysis by Eyestock methodology
Valuation
STX.L valuation using historical relative method
Statements
STX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
STX.L dividend yield and annual dividend
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
Shield Therapeutics`s Average growth rate (2y) for the period ended 2024-06-30 is 2 %
